Erratum to: Comparison of Pulmonary Involvement Between Patients Expressing Anti-PL-7 and Anti-Jo-1 Antibodies (Lung, (2015), 193, (79-83), 10.1007/s00408-014-9665-7);Comparison of Pulmonary Involvement Between Patients Expressing Anti-PL-7 and Anti-Jo-1 Antibodies

Lung

Volumn 193, Issue 1, 2015, Pages 79-83

  Tomonaga, Masaomi ^a   Sakamoto, Noriho ^a   Ishimatsu, Yuji ^a   Kakugawa, Tomoyuki ^a   Harada, Tatsuhiko ^a   Nakashima, Shota ^a   Hara, Atsuko ^a   Hara, Shintaro ^a   Horai, Yoshihiro ^b   Kawakami, Atsushi ^b   Mukae, Hiroshi ^c   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Antisynthetase syndrome; Dermatomyositis; Interstitial lung disease; Polymyositis

Indexed keywords

ANTIBODY; IMMUNOSUPPRESSIVE AGENT; JO 1 ANTIBODY; PL 7 ANTIBODY; PREDNISOLONE; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; BIOLOGICAL MARKER; JO-1 ANTIBODY; THREONINE TRANSFER RNA LIGASE;

ADULT; ANTISYNTHETASE SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; LYMPHOCYTE; MALE; ORGANIZING PNEUMONIA; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; BLOOD; COMPLICATION; CRYPTOGENIC ORGANIZING PNEUMONIA; IMMUNOLOGY; LUNG; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; MYOSITIS; PREDICTIVE VALUE; RADIOGRAPHY; RETROSPECTIVE STUDY;

ADULT; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; CRYPTOGENIC ORGANIZING PNEUMONIA; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYOSITIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; THREONINE-TRNA LIGASE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84938063114     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-016-9924-x     Document Type: Erratum

References (18)

1. Hervier B, Devilliers H, Stanciu R et al (2012) Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev 12:210–217
2. Ronnelid J, Barbasso Helmers S, Storfors H et al (2009) Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev 9:58–61
3. Hamaguchi Y, Fujimoto M, Matsushita T et al (2013) Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 8:e60442
4. Hervier B, Benveniste O (2013) Clinical heterogeneity and outcomes of antisynthetase syndrome. Curr Rheumatol Rep 15:349
5. Marie I (2012) Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 14:275–285
6. Marie I, Josse S, Decaux O et al (2013) Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome. Eur J Intern Med 24:474–479
7. Tillie-Leblond I, Wislez M, Valeyre D et al (2008) Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 63:53–59
8. Ingegnoli F, Lubatti C, Ingegnoli A et al (2012) Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature. Autoimmun Rev 11:335–340
9. Marie I, Josse S, Hatron PY et al (2013) Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome. Arthritis Care Res 65:800–808
10. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407
11. Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626–636
12. Sakamoto N, Mukae H, Fujii T et al (2004) Soluble form of Fas and Fas ligand in serum and bronchoalveolar lavage fluid of individuals infected with human T-lymphotropic virus type 1. Respir Med 98:213–219
13. Meyer KC, Raghu G, Baughman RP et al (2012) An official american thoracic society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185:1004–1014
14. American Thoracic Society ERS (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. international consensus statement. Am J Respir Crit Care Med 161:646–664
15. Hervier B, Uzunhan Y, Hachulla E et al (2011) Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies. Eur Respir J 37:714–717
16. Schnabel A, Reuter M, Biederer J et al (2003) Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 32:273–284
17. Marie I, Josse S, Decaux O et al (2012) Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11:739–745
18. Aggarwal R, Cassidy E, Fertig N et al (2014) Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 73:227–232